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struction, the completeness of revascularization, the con-
figuration of bypass grafts, and the best conduit material.
The literature is scarce with long-term results of mesen-
teric artery revascularization with objective documenta-
tion of bypass graft patency. The purpose of the study was
to address these controversial issues and to determine the
late results after mesenteric artery reconstruction (MAR)
for atherosclerotic mesenteric ischemia with the review of
a 37-year experience at the Henry Ford Hospital.
MATERIALS AND METHODS
The clinical data for all the patients who underwent
major arterial reconstructions at the Henry Ford Hospital
have been entered in an ongoing vascular surgery registry.
The management and outcome were reviewed for 48 con-
secutive patients who underwent MAR for nonembolic,
atherosclerotic mesenteric ischemia from June 1963
through July 2000, and this review forms the basis of this
report. Specifically excluded were patients who had
mesenteric ischemia of embolic origin develop and those
asymptomatic patients who underwent MAR during repair
of abdominal/thoracoabdominal aortic aneurysms. The
atherosclerotic nature of the lesion was determined with
information from the registry and with review of preoper-
ative arteriography and operative notes.
Since the first account of local endarterectomy (LEA)
of the superior mesenteric artery (SMA) by Shaw and
Maynard1 in 1958, various techniques of mesenteric revas-
cularization have been advanced, including reimplanta-
tion, angioplasty, transaortic endarterectomy (TAE), and
bypass grafting (BPG) with either autogenous or pros-
thetic grafts.2-5 Today, the management of symptomatic
mesenteric ischemia remains a compelling challenge for
the vascular surgeon. Acute mesenteric ischemia (AMI) is
plagued with a high mortality rate of 70%. Because of its
rarity, a unified, standardized approach does not yet exist
for the treatment of this entity, and thus, controversy
remains with respect to the optimal method of recon-
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Purpose: The purpose of this study was the definition of the late results and determining factors after mesenteric artery
reconstruction (MAR) for atherosclerotic mesenteric ischemia.
Methods: A retrospective review identified 48 consecutive patients (66 arteries) who underwent MAR for acute mesen-
teric ischemia (AMI) of nonembolic origin (n = 23; 12 with and 11 without prior symptoms) and chronic mesenteric
ischemia (CMI; n = 25) from 1963 to 2000 in a tertiary care referral center. The 29 women (60%) and the 19 men
(40%) had a mean age of 64 years (range, 40 to 87 years). The operative procedures consisted of bypass grafting in 36
arteries (AMI, 12; CMI, 24), local endarterectomy (LEA) in 16 arteries (AMI, 9; CMI 7), and transaortic endarterec-
tomy (TAE) in 14 arteries (AMI, 4; CMI, 10). The follow-up of the 34 survivors was complete in all but four patients
and averaged 5.3 years (range, 30 days to 36 years). Radiographic documentation of vessel/graft patency was obtained
in 33 of 34 survivors.
Results: Single-vessel revascularization was performed more frequently in the AMI group than in the CMI group (91%
versus 48%; P = .001). The perioperative (<30 days) mortality rate in the AMI group was 52% (12 of 23 cases) as com-
pared with 0 of 25 cases in the CMI group (P < .001). Bowel infarction was the cause of nine deaths. Major compli-
cations occurred in 60% of the cases. Fifteen late graft failures occurred, for a cumulative patency rate of 57% at 5 years
and 46% at 10 years. TAE was associated with improved patency rates as compared with LEA (TAE versus LEA; P =
.002). Symptomatic recurrences developed in eight patients, all involving superior mesenteric artery thrombosis (P <
.001). The freedom-from-recurrence rates in the survivors were 79% at 5 years and 59% at 10 years. The late survival
rates were 54% and 20% at 5 and 10 years, respectively. With the exclusion of perioperative deaths, the probability of
long-term survival was 77% at 5 years and 29% at 10 years and did not differ between AMI and CMI.
Conclusion: Although MAR for CMI carries a low mortality rate, AMI remains a lethal and frequently unheralded prob-
lem. Long-term patency and symptom-free survival can be expected after successful MAR for AMI and is comparable
with those rates achieved after MAR for CMI. The patency of the SMA is important in the prevention of symptomatic
recurrences. Elective MAR is indicated in patients with CMI and warrants long-term surveillance. (J Vasc Surg
2002;35:453-60.)
The following numbers of patients underwent opera-
tion during each decade of the study: four patients from
1963 to 1970, seven patients from 1971 to 1980, 15
patients from 1981 to 1990, and 22 patients from 1991 to
2000. All the medical records, including hospital and
office charts, were reviewed. All available angiographic
and other imaging study results were reviewed. Clinical
follow-up examination was complemented with review of
the medical record and with telephone contact with the
patient, the family, or the referring physician.
The analysis of data was performed with the log-rank
and χ2 tests, and the graft patency, freedom-from-recur-
rence, and survival rates were calculated with the Kaplan-
Meier method. The analyses were performed to determine
the effects of different variables, including presentation
(acute versus chronic), revascularization method (LEA
versus TAE versus BPG), graft type (vein versus pros-
thetic), graft configuration (antegrade versus retrograde),
and completeness of revascularization.
RESULTS
Presentation. The 29 female patients (60%) and the
19 male patients (40%) had a mean age of 64.2 ± 10.6 years
(range, 40 to 87 years). Twenty-five patients (52%) were
seen with symptoms of chronic mesenteric ischemia
(CMI), and 23 (48%) were seen with AMI. Twelve of these
23 patients with AMI (52%) had symptoms of CMI. Most
of the patients (90%) were white. One patient had previ-
ously undergone retrograde BPG to the celiac artery and
the SMA at a referring hospital. Seven patients had under-
gone prior peripheral arterial reconstructions, including
aortobifemoral BPG (n = 3), abdominal aortic aneurysm
repair (n = 1), femoropopliteal BPG (n = 1), carotid
endarterectomy (n = 1), and axillobifemoral BPG (n = 1).
The presenting symptoms are summarized in Table I.
All the patients had abdominal pain. An average weight
loss of 16 kg (range, 5 to 27 kg) was noted in 60% of the
patients. Smoking was the most common risk factor
(75%), followed by hypertension (60%), coronary artery
disease (50%), and hyperlipidemia (27%). Diabetes melli-
tus was observed in only four patients (8%).
Angiographic findings. Angiography was performed
in 45 patients (88%); three patients underwent emergency
operation without the benefit of either preoperative
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Table I. Clinical presentation
No. of patients
Sign/symptom Acute Chronic Total
Abdominal pain 23 (100%) 25 (100%) 48 (100%)
Weight loss 8 (35%) 21 (84%) 29 (60%)
Nausea/emesis 13 (57%) 9 (36%) 22 (46%)
Diarrhea 12 (52%) 8 (32%) 14 (29%)
Food fear 2 (9%) 4 (16%) 6 (13%)
Table III. Method of mesenteric reconstruction
No. of vessels
Acute Chronic Total
Bypass grafting 12 (48%) 24 (59%) 36 (55%)
Local endarterectomy 9 (36%) 7 (17%) 16 (24%)
Transaortic endarterectomy 4 (16%) 10 (24%) 14 (21%)
Total 25 41 66
Table V. Method of mesenteric reconstruction by decade
No. of vessels
LEA TAE BPG Total
1963-1970 2 (40%) 0 3 (60%) 5
1971-1980 3 (43%) 0 4 (57%) 7
1981-1990 2 (10%) 10 (48%) 9 (43%) 21
1991-2000 9 (27%) 4 (12%) 20 (61%) 33
LEA, Local endarterectomy; TAE, transaortic endarterectomy; BPG,
bypass grafting.
Table IV. Extent of mesenteric reconstruction
No. of patients
Acute Chronic Total
One-vessel reconstruction 21 (91%) 12 (48%) 33 (69%)
SMA 20 12 32
Celiac 1 0
IMA 0 0
Two-vessel reconstruction 2 (9%) 10 (40%) 12 (25%)
Celiac and SMA 2 8
Celiac and IMA 0 1
SMA and IMA 0 1
Three-vessel reconstruction
Celiac, SMA, and IMA 0 3 (12%) 3 (6%)
Total 23 25 48
SMA, Superior mesenteric artery; IMA, inferior mesenteric artery.
Table II. Distribution of mesenteric atherosclerosis
No. of patients
Sign/symptom Acute Chronic Total
Three-vessel disease
Celiac, SMA, and IMA 7 (30%) 20 (80%) 27 (56%)
Two-vessel disease
Celiac and SMA 7 (30%) 3 (12%) 10 (21%)
SMA and IMA 4 (17%) 2 (8%) 6 (13%)
Single-vessel disease (SMA) 2 (9%) 0 2 (4%)
Unknown* 3 (13%)
Total 23 25 48
*Those patients who underwent mesenteric artery reconstruction without
preoperative arteriography and postmortem study.
SMA, Superior mesenteric artery; IMA, inferior mesenteric artery.
angiography or autopsy, and thus, the extent of mesenteric
atherosclerosis could not be defined. Occlusion or severe
stenosis that involved the SMA was present in all the
patients who underwent angiography. Twenty-seven
patients (57%) had three-vessel disease, 16 (33%) had two-
vessel disease, and only two had single-vessel (SMA) dis-
ease (Table II).
Surgical reconstruction. The details of the 48
mesenteric revascularizations that involved 66 arteries are
summarized in Tables III and IV. Single-vessel recon-
struction was performed in 33 patients (69%), and multi-
vessel reconstruction was performed in 15 patients (31%).
All but one patient underwent SMA revascularization.
Concomitant aortic procedures were performed in 12
patients (25%). The patients with AMI were more likely to
undergo a single-vessel reconstruction than were the
patients with CMI (91% versus 48%; P = .001). There was
no substantial difference in the method of reconstruction
between the AMI and CMI groups (Table III). Although
the patients with AMI tended to undergo more LEAs than
did the patients with CMI, statistical significance was not
observed (P = .13).
BPG was the most common method of reconstruction
and was performed on 36 vessels (55%) in 30 patients.
Graft configurations were antegrade in 21 grafts and ret-
rograde in 15. Inflow sources for retrograde grafts were
infrarenal aorta (n = 8), iliac (n = 3), renal (n = 3), and
splenic arteries (n = 1).
BPG was performed with similar frequency with auto-
genous veins (n = 20) and prosthetic grafts (n = 16). Of
the 20 vein grafts performed, 13 were constructed in a ret-
rograde fashion. Three of these retrograde grafts throm-
bosed early, which accounted for the two perioperative
mortalities and a third death 2 months later.
Increasingly complex reconstructions were performed
during the four decades of the study (Table V). LEA was
performed in 42% of the vessels in the first half of the
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series but accounted for only 20% of the cases in the sec-
ond half. The decrease in the number of LEAs and the
increase in the number of TAEs and BPGs were statisti-
cally significant (P = .04) and coincide with the introduc-
tion of TAE in the late 1970s.2 During the last decade,
antegrade BPG was the most common method of recon-
struction (80%; 16 of 20 arteries). This is a significant
change when compared with the first three decades (31%;
5 of 16 arteries; P = .006).
Perioperative bowel resection was necessary in 20
patients, all but one of whom was seen with AMI (83% for
AMI versus 4% for CMI). “Second-look” operations were
performed in 10 patients, all of whom underwent further
bowel resection.
Morbidity and mortality rates. The overall periop-
erative (<30 days) mortality rate was 25% (12 of 48 cases):
52% (12 of 23 cases) for AMI and 0 of 25 cases for CMI
(P < .001). Advanced age and acute presentation were
associated with mortality (Table VI). Another related fac-
tor was the completeness of revascularization. This can be
explained by the fact that extensive revascularization could
not be performed in those patients with AMI caused by
their critical condition. Bowel resection was necessary in
86% of the AMI cases versus 4% of the CMI cases. Indeed,
all mortality occurred after a single-vessel revascularization
to the SMA. Bowel ischemia was the cause of death in nine
patients, including eight of 10 patients who underwent a
“second-look” operation. Two additional deaths, one in
each group, occurred during prolonged hospitalization,
for an in-hospital mortality rate of 29%: 57% for the AMI
group and 4% for the CMI group. One patient in the AMI
group died from multisystem organ failure on postopera-
tive day 160 after LEA of the SMA. The only death in the
CMI group occurred on postoperative day 112 in a
woman who underwent TAE of the celiac artery and the
SMA. The patient died of pneumonia. Early graft throm-
bosis accounted for two deaths. Both patients had under-
Table VI. Factors associated with long-term and symptom-free survival rates
All patients Hospital survivors
Long-term Symptom-free Long-term Symptom-free 
survival rate survival rate survival rate survival rate 
(P value) (P value) (P value) (P value)
Acute versus chronic presentation .003 .03 .9 1.0
Multivessel versus single-vessel reconstruction .02 .1 .3 .7
Concomitant aortic reconstruction .1 .4 .6 .6
Female gender .5 .4 .2 .1
Hyperlipidemia .9 .6 .4 .9
Hypertension .1 .7 .8 .9
Diabetes mellitus .7 .9 .7 .5
Smoking .8 .8 .4 .1
COPD .7 .4 .9 .5
CAD .3 .2 .9 .3
PVOD .1 .1 .6 .3
Age .02 .3 .6 .9
P values determined with log-rank test.
COPD, Chronic obstructive pulmonary disease; CAD, coronary artery disease; PVOD, peripheral vascular occlusive disease.
gone bowel resection and retrograde aorto-SMA bypass
grafting procedures with vein. Another patient died of
liver and bowel infarction at 3 days after an unsuccessful
SMA thromboendarterectomy. The long-term survival
rate of the early survivors was not affected by any of these
variables.
Postoperative complications were common and
occurred in 29 patients (60%). Pulmonary complications
were the most frequent (23%), followed by sepsis, renal
insufficiency, bowel ischemia (15%), and cardiac morbidity
(15%). No significant difference in morbidity rate was
noted between different methods of reconstruction, graft
configuration, or completeness of revascularization.
Concomitant aortic reconstruction was performed in 10
patients and was not associated with a significant increase
in morbidity rate (58% versus 47%).
Although the overall morbidity rate trended down-
ward in the later decades of the study, statistical signifi-
cance was not observed. Morbidity rate by decade was as
follows: 75% (3 of 4 patients) from 1963 through 1970,
71% (5 of 7 patients) from 1971 through 1980, 47% (7 of
15 patients) from 1981 through 1990, and 41% (9 of 22
patients) from 1991 through 2000. The lack of statistical
significance may be, in part, the result of the small num-
ber of patients in the earlier decade of the series.
Long-term outcome. At the last follow-up examina-
tion, the details of functional status and causes of deaths
were determined for all but four of 34 survivors (88%).
The average follow-up period was 5.3 years (range, 30
days to 36.3 years). Radiographic documentation of ves-
sel/graft patency was obtained at least once for all the sur-
vivors except one. The mean time from MAR to last
imaging was 3.1 years (range, 3 days to 20.4 years).
Late deaths occurred in 16 patients (3 in the AMI
group and 13 in the CMI group). The causes were coro-
nary disease in six cases, recurrent mesenteric ischemia in
four cases, malignancy in four cases, and ruptured renal
artery pseudoaneurysm in one case. The cause was
unknown in one patient. Recurrent mesenteric ischemia
resulted in deaths at 2 months, 5 months, 21 months, and
41 months after MAR. Overall late survival rates were 54%
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Fig 1. Long-term survival rate of perioperative survivors of
mesenteric artery reconstruction (Kaplan-Meier method).
Fig 2. Long-term survival rate of perioperative survivors of
mesenteric artery reconstruction: acute mesenteric ischemia ver-
sus chronic (Kaplan-Meier method).
Fig 3. Long-term primary patency rate of reconstructed mesen-
teric arteries (Kaplan-Meier method).
Table VII. Factors associated with graft/vessel patency
rate
Graft/vessel patency rate 
Factors (P value)
Presentation
Acute versus chronic .2
Vessel type
IMA versus SMA versus celiac artery .7
Revascularization type
LEA versus TAE versus BPG .05
Graft type
Vein versus prosthetic .1
Inflow source 
Aortic versus nonaortic 1.0
Configuration
Antegrade versus retrograde .5
P values determined with log-rank test.
IMA, Inferior mesenteric artery; SMA, superior mesenteric artery; LEA,
local endarterectomy; TAE, transaortic endarterectomy; BPG, bypass 
grafting.
and 20% at 5 and 10 years, respectively. With the exclusion
of perioperative deaths, the probability of survival at 5
years was 77% and at 10 years was 29% (Fig 1; Table V).
There was no significant difference between the patients
with AMI and those with CMI. In this cohort, the prob-
ability of long-term survival was equivalent between the
AMI and CMI groups (Fig 2).
The long-term patency rate of the 66 grafts/vessels is
depicted in Fig 3. For the analysis of the graft/vessel
patency rate, the date of occlusion was estimated as the
midpoint between the dates of last known patency and
documentation of graft/vessel thrombosis. Graft stenosis
that needed reintervention was considered as an occlusion
for the calculation of patency rate. Late occlusion was doc-
umented in 15 grafts/vessels of 13 patients. The overall
long-term primary patency rate was 57% and 46% at 5 and
10 years, respectively (Fig 3; Table VII).
Of the variables that were studied, only the method of
revascularization was found to have an effect on patency
rate (Table VII). TAE was associated with improved
patency rate as compared with LEA (TAE versus LEA;
log-rank test, P = .002), whereas no significant difference
was noted between TAE and BPG (Fig 4). The long-term
patency rates did not differ between the AMI and CMI
groups (Fig 5).
Five of 13 patients with failed reconstructions re-
mained asymptomatic, and eight had symptoms develop.
Thus, the freedom-from-recurrence rate in the survivors
was 79% at 5 years and 59% at 10 years (Fig 6; Table VII).
It is noteworthy that all the symptomatic recurrences
occurred when an SMA reconstruction failed, and none of
the asymptomatic graft/vessel thrombosis involved SMA
occlusion (P < .001). The asymptomatic reconstruction
failures involved occlusion of three IMAs and two celiac
artery trunks. Five of the eight patients with recurrences
underwent reintervention; one had angioplasty with stent
implantation, and four had reoperations. The patient who
underwent stenting remains symptom free 7 years later.
Two patients obtained symptomatic relief after reopera-
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tions and died of malignancy 4 and 8 years later. One
patient in whom recurrence developed after LEA of SMA
underwent antegrade celiac BPG. However, the patient
never recovered from the second operation and became
dependent on total parenteral nutrition and died of line
sepsis 21 months later. One patient died during a third
revascularization attempt.
Of the three patients who remained symptomatic, two
died without a secondary operation. The final patient was
a 91-year-old woman who underwent TAE of the celiac
artery trunk and SMA 18 years ago. At a 17-year follow-
up examination, the patient was found to have occluded
both visceral arteries but remained asymptomatic with the
bowels supplied with a patent meandering mesenteric
artery. Subsequently, the patient had recurrent symptoms
develop with an 18-kg weight loss but has refused reinter-
vention at the time of writing. Thus, four deaths have
resulted from reconstruction failure. Conduit material,
inflow source, method of reconstruction, graft configura-
tion, and the completeness of revascularization were not
associated with symptomatic recurrences (Table VI).
Fig 4. Long-term patency rate of reconstructed mesenteric arter-
ies with revascularization method (Kaplan-Meier method). TAE,
Transaortic endarterectomy; BPG, bypass grafting; LEA, local
endarterectomy.
Fig 5. Long-term patency rate in survivors of mesenteric artery
reconstruction: acute mesenteric ischemia versus chronic (Kaplan-
Meier method).
Fig 6. Long-term freedom-from-recurrence rate (Kaplan-Meier
method).
DISCUSSION
This series illustrates the evolution of the surgical
management of mesenteric ischemia during four decades
and provides the longest follow-up data on MAR with
objective assessment of graft patency. Evolution in surgical
techniques and improvements in perioperative care have
made it possible for more complex and extensive MAR.
Although LEA constituted 42% of MAR in the first two
decades, it accounted for 20% in the last two decades.
Similarly, multivessel reconstruction was performed more
commonly in the second half of the series as compared
with the first half. In fact, all the three-vessel reconstruc-
tions were performed after 1990, and 11 of 12 two-vessel
reconstructions were performed after 1980. Currently,
celiac artery and SMA reconstruction with antegrade BPG
is the preferred method of MAR at our institution.
Mesenteric reconstruction for the treatment of CMI
can be performed safely and effectively with a good long-
term outcome. In contrast, AMI remains a lethal problem
with an exceedingly high mortality rate. Nevertheless, the
cumulative long-term survival rate of those who survived
their initial procedure was not affected by the acuity of
presentation. Similar long-term primary patency rates
were achieved for both TAE and BPG. Thrombosis of
SMA reconstruction was associated with symptomatic
recurrences. Conduit material, graft configuration, and
completeness of revascularization did not influence late
survival, patency, or freedom-from-recurrence rates.
Failure to show any differences related to these factors in
this series and in others reflects the small size of the series
and the fact that most MAR methods achieve symptomatic
relief with good short-term patency.6-9 A large number of
patients would be needed to generate statistical power for
the detection of any differences.
There are several limitations with this study. First, this
series encompasses experience during four decades with a
number of different surgeons. The results reflect the evo-
lution of surgical treatment and of surgeon preferences
during this period and not a unified, standardized
approach. Second, this experience involves a relatively small
number of patients. Third, it has the usual shortcomings of
any retrospective study. These limitations, however, under-
score a problem common in mesenteric ischemia: its rarity.
It is unlikely that a single center can collect a large enough
series during a short period to provide convincing data
from a prospective randomized study. The results of this
study, however, are comparable with the literature.
The question of optimal graft material remains con-
troversial.9,10 Although some study results have shown
favorable results with saphenous vein,11,12 there have been
reports of improved patency rates with prosthetic
grafts.2,10,13 Several groups have noted a high failure rate
with vein graft and have abandoned its use.14 However,
most of the studies lack objective assessment of graft
patency. In a study with objective documentation of graft
patency, McMillan et al8 did not observe a difference in
long-term patency rate between expanded polytetrafluo-
roethylene and saphenous vein. The clear advantage of
autogenous saphenous vein over prosthetic graft observed
in other vascular beds is not so evident in the mesenteric
tree. The authors’ current policy is to use prosthetic grafts
unless there is obvious contamination of the peritoneal
cavity or when the reconstruction is carried to a site distal
to the main visceral arteries or to branches thereof.
Another controversial issue in MAR is the configura-
tion of bypass graft. Retrograde BPG to the SMA and the
celiac trunk from the infrarenal aorta was first introduced
in 1962 by Morris et al15 and still is probably the most
commonly performed procedure for both AMI and CMI.
Satisfactory results with this approach have been reported
by several authors.11,16,17 Recently, in a review of 49
patients with single retrograde BPG to the SMA for symp-
tomatic mesenteric ischemia, Foley and associates16
showed the efficacy and durability of retrograde BPG with
a 9-year assisted primary graft patency rate of 79%.
The prevalence of disease in the infrarenal aorta and
proximal iliac arteries, however, may preclude the use of
retrograde BPG without concomitant aortic replacement.
The propensity of the grafts to kink when the abdominal
viscera are returned to their normal anatomic position
raises another concern.4,18 In addition, an isolated retro-
grade bypass graft to the mid SMA, when thrombosed,
may jeopardize critical reentry collaterals from the celiac
trunk and IMA and result in gut infarction.19 Antegrade
BPG, in comparison, originates from the relatively disease-
free supraceliac aorta and resists kinking better than the
retrograde bypass graft.3,18 It requires shorter graft
length, provides direct in-line flow with low turbulence,
and avoids direct contact with bowel. Indeed, this method
has become the preferred choice for many sur-
geons.3,4,6,20,21 The authors’ current experience reflects
this trend. During the last decade, 80% of our bypass
grafts were constructed in an antegrade fashion. Although
no measurable difference in long-term primary patency
rate or freedom-from-recurrence rate could be found
between the two configurations in this series, the authors
prefer antegrade BPG.
Another question in MAR relates to the priority of
vessel. The group at the University of California–
San Francisco suggested that the celiac trunk is the most
important vessel to revascularize. They reported that all
known celiac axis reocclusions have resulted in sympto-
matic recurrences, even with a patent SMA.4 In contrast,
Moneta et al22 believe that the SMA is the critical vessel in
MAR on the basis of the fact that the SMA carries most of
the increased blood flow during hyperemic postprandial
state, an effect not observed in the celiac artery. The sig-
nificance of SMA patency found in the current series is in
accord with the latter. All symptomatic relapses in this
study occurred when the SMA reconstruction occluded,
whereas no asymptomatic reconstruction failures involved
SMA occlusion. A patent celiac trunk did not prevent
symptomatic relapse when SMA reconstruction failed,
even in the presence of diseased but patent IMA, a finding
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that echoes an earlier writing of Stoney, Ehrenfeld, and
Wylie2 in which patency of IMA was emphasized when
reconstruction of the celiac axis alone was performed.
A final issue in MAR is the number of vessels to repair.
Single-vessel reconstruction is commonly performed with
good long-term outcome. In a series at the University of
California–San Francisco, Cunningham et al3 reported a
symptom relief rate at 5 years of 86%. The rate for single-
vessel BPG was 76%. This difference was not statistically dif-
ferent because of the small number of patients in the BPG
group, and they concluded that durable relief of symptoms
did not correlate with the number of visceral arteries revas-
cularized. It is of interest to note that Stoney and associates
at the University of California–San Francisco revascularize
both the celiac artery and the SMA whenever possible.19,23
Kieny, Batelliler, and Kretz21 observed an 8.3% recur-
rence rate during 8.5 years of follow-up of 60 isolated
SMA reimplantations. Similarly, Cormier et al14 reported
a 4.8% recurrence rate at an average of 69 months of fol-
low-up in 103 patients, of whom 63% underwent single-
vessel reconstruction. Recently, Foley and associates16
reported a 6% 5-year recurrence rate after 49 retrograde
SMA BPG procedures and asserted that additional BPG to
other visceral arteries was “unnecessary.” Christensen,
Lorentzen, and Schroeder24 advocated isolated SMA
reconstruction in their review of 90 patients on the basis
of simplicity and low operative mortality rate. However,
the patients in this series had a 33% recurrence rate during
a median of 55 months of follow-up.
The proponents of multivessel revascularization state
that the incidence rate of recurrence with multivessel BPG
is lower when compared with single-vessel BPG when graft
thrombosis occurs. As observed in this study, a graft/ves-
sel thrombosis after multivessel revascularization usually
does not present with clinical consequences. In a Mayo
Clinic series, Hollier et al11 espoused complete revascular-
ization after they observed a 50% recurrence rate when
only one of three arteries was reconstructed as compared
with 11% after repair of all diseased arteries. This finding
persisted in a later Mayo Clinic study when McAfee and
associates20 showed improved graft patency and survival
rates with complete revascularization. The 5-year graft
patency rates were 90%, 54%, and 0 with three-vessel, two-
vessel, and one-vessel reconstructions, respectively, and the
respective survival rates were 73%, 57%, and 0. In a series
from the Cleveland Clinic, Mateo and colleagues10 noted
lower 5-year survival and symptom-free-survival rates in
those patients with incomplete revascularization. Most
investigators now endorse revascularization of at least the
celiac trunk and the SMA on similar grounds.6
Clearly, late MAR failure occurs not uncommonly with
the incidence rates of reported symptomatic recurrences
varying from 11% to 50%,6,8,9,11,12,25 with concomitant
high mortality rates.11,12 Recurrent AMI in the periopera-
tive period is uniformly fatal in most series.6,11,12,25 It also
appears that the fate of a patient whose isolated SMA
bypass graft fails differs from that of a patient who has both
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celiac trunk and SMA reconstructed. In a series that
reports single-vessel BPG to the SMA, two of three
patients with late graft failures (67%) died.17 In contrast,
after multivessel reconstruction, only seven of 19 patients
with recurrences (37%) were seen acutely, 86% of whom
died.25 In this series, 50% of symptomatic recurrences
resulted in death. In light of the grave consequences of
recurrent mesenteric ischemia and the possible reduction
in the incidence of this problem with complete revascular-
ization, it has been our recent practice to perform multi-
vessel revascularization whenever safe and feasible.
Progress in anesthetic techniques and postoperative critical
care has made routine multivessel reconstruction possible
without an attendant increase in morbidity rate.
Progression of mesenteric atherosclerosis to thrombo-
sis is estimated to account for 20% to 50% of AMI.26,27
A study on the clinical course of asymptomatic mesenteric
atherosclerosis showed that 27% of patients with three-
vessel disease ultimately had mesenteric ischemia
develop.28 Rheudasil and colleagues6 observed that seven
of 41 patients had acute symptoms develop while waiting
in the hospital for elective MAR, which resulted in one
death. AMI may also develop after aortic reconstruction in
patients with severe mesenteric atherosclerosis and is
termed “mesenteric steal syndrome.”29 For these reasons,
some authors recommend prophylactic MAR during aor-
tic procedures if it can be done without an increase in
morbidity rate and if patients have a three-vessel dis-
ease.6,14,28,30,31
In this series, no added morbidity occurred with con-
comitant aortic reconstruction. Increased morbidity, how-
ever, may accompany prophylactic revascularization. In a
Mayo Clinic series, a 19% mortality rate (4 of 21 cases) was
observed with simultaneous aortic reconstruction as com-
pared with 5% (2 of 37 cases) without.20 Rapp and
coworkers4 reported a mortality rate of 33% (5 of 15
patients) when combined with aortic and renal recon-
struction. Proper patient selection, therefore, seems criti-
cal for a successful prophylactic MAR.
In summary, MAR for chronic symptoms can be per-
formed safely and effectively with a low mortality rate.
AMI, however, remains a lethal and frequently unheralded
problem. The success of MAR depends on timing and
technical precision, not on conduit material, method of
reconstruction, graft configuration, or completeness of
revascularization. The authors prefer, however, to perform
antegrade multivessel reconstruction when possible.
Vigilant surveillance and preservation of SMA patency is
most important in the prevention against symptomatic
recurrences. Because survivors of AMI have comparable
long-term patency8 and survival rates with those survivors
of CMI, an aggressive approach should be adopted
towards surgical revascularization for AMI.
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